Form 4 for RXST RxSight, Inc.
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0000950170-24-010565 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-02 | 2024-02-01 | RXST | Goldshleger Ilya | COO | M - OptEx | $19.24 | +7,129 | 33.6K | +27% | +$137.2K |
| DMT | 2024-02-02 | 2024-02-01 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $49.29 | -7,129 | 26.5K | -21% | -$351.4K |
| DMT | 2024-02-02 | 2024-02-01 | RXST | Goldshleger Ilya | COO | M - OptEx | $0.00 | -7,129 | 30.0K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 6,539 | $18.90 | 33,014 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-01 | M | A | 590 | $23.04 | 33,604 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 3,539 | $49.00 | 30,065 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-01 | S | D | 3,000 | $49.50 | 27,065 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-01 | S | D | 590 | $50.00 | 26,475 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-02-01 | M | D | 6,539 | $0.00 | 7,981 | D | $18.90 · 2022-01-25 to 2028-01-24 | 6,539 Common Stock | |
| 7 | Derivative | Stock Option (right to buy) | 2024-02-01 | M | D | 590 | $0.00 | 30,000 | D | $23.04 · 2021-04-18 to 2029-04-17 | 590 Common Stock |